Skip to content
Open access

Structural, spectroscopic, thermal and biological insights into a new cadmium halide-based organic–inorganic hybrid material

Sep 2026 · RSC Advances · 0 citations · 68 references
Medicine

Abstract

A novel cadmium halide-based organic–inorganic hybrid material, (2A4PH)2[CdBr4] (where 2A4PH denotes the 2-amino-4-methylpyridinium cation), was synthesized at room temperature using a Schlenk method and comprehensively characterized by single-crystal X-ray diffraction, spectroscopic, thermal, and biological investigations. The compound crystallizes in the monoclinic space group P21/n and consists of isolated tetrahedral [CdBr4]2− anions incorporated within a matrix of protonated aminopyridinium cations. The crystal structure is stabilized by an extensive network of N–H⋯Br hydrogen bonds and π–π stacking interactions, which contribute to the overall cohesion of the hybrid framework. Hirshfeld surface analysis highlights the predominance of H⋯Br contacts among the intermolecular interactions, while FTIR and Raman spectroscopy confirm the characteristic vibrational modes of the organic and inorganic components. Thermal analysis (TGA/DSC) reveals good thermal stability over a moderate temperature range, followed by a decomposition process leading to the formation of CdBr2. Furthermore, the biological potential of (2A4PH)2[CdBr4] was investigated through antioxidant and α-amylase inhibition assays. The hybrid material exhibited notable radical-scavenging activity toward DPPH and ABTS radicals, whereas a lower ferric-reducing capacity was observed. Enzyme inhibition studies demonstrated a mixed-type inhibition mechanism against α-amylase. These findings provide valuable insights into the structure–property relationships of cadmium halide-based hybrid materials and highlight (2A4PH)2[CdBr4] as a promising multifunctional hybrid system with potential relevance in bioactive material applications.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.